Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,863,541
+$574,741 QoQ
Shares Held
34,250
+14.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#270
of 751 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CreativeOne Wealth, LLC holds $11,639,856 across 13 Biotechnology names. EXEL ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
38,953 | $3,048,850 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
34,250 | $1,863,541 | |
| 3 | MRNA |
Moderna, Inc.
|
22,494 | $1,575,254 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
8,290 | $1,552,550 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,183 | $1,084,361 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
126,926 | $1,062,370 | |
| 7 | MGTX |
MeiraGTx Holdings plc
|
26,424 | $356,988 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
571 | $356,041 |
All Filings in EXEL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,863,541 | 34,250 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,288,800 | 30,049 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,667,775 | 38,051 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,325,812 | 32,102 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $599,796 | 13,607 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $294,510 | 7,977 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $399,600 | 12,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $203,370 | 7,837 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||